The Effect of Blood Flow Restriction Training on Tennis Elbow

Launched by CAIRO UNIVERSITY · Jun 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a special type of exercise called blood flow restriction training can help people with tennis elbow, a painful condition affecting the outer part of the elbow. The researchers want to find out if this training is more effective than regular strength training in reducing pain, improving disability, and increasing grip strength in patients with tennis elbow. To do this, they will divide participants into two groups: one will do the blood flow restriction training along with regular therapy, while the other will just do the standard therapy without any special training.

To be eligible for the trial, participants must be between 20 and 40 years old, have been diagnosed with tennis elbow in their dominant arm for less than three months, and show signs of decreased grip strength and wrist movement. They should not have received any physical therapy for tennis elbow in the past six months. However, individuals with certain health issues, such as diabetes, recent upper arm injuries, or high blood pressure, are not eligible to participate. If you join the study, you can expect to follow a rehabilitation program while helping researchers learn more about treatment options for tennis elbow.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients that were included in this study were diagnosed with lateral epicondylitis by a medical doctor for less than 3 months.
• • Dominant hand was diagnosed with lateral epicondylitis.
• • They were aged between 20 and 40 years old.
• • With decreased grip strength and wrist range of motion.
• • No history of physical therapy treatment for lateral epicondylitis for at least 6 months.
• Exclusion Criteria:
• • Patients with chronic diabetes.
• • Any type of trauma or fracture in the upper extremities in the last 3 months.
• • Patients with any vestibular problems.
• • Patients with deep vein thrombosis (DVT).
• • Patients with hypertension.
• • Patients with cancer.